Clinical overview on Lipoplatin™: a successful liposomal formulation of cisplatin

Pemetrexed as second-line therapy for advanced non-small-cell lung cancer (NSCLC)

(2016) Enriqueta Felip   Therapeutics and Clinical Risk Management

Lipoplatin™ Monotherapy: A Phase II Trial of Second-Line Treatment of Metastatic Non-Small-Cell Lung Cancer

(2014) A. Ravaioli et al.   JOURNAL OF CHEMOTHERAPY

Targeting Poly (ADP) Ribose Polymerase I (PARP-1) and PARP-1 Interacting Proteins for Cancer Treatment

(2012) Elza Sakamoto-Hojo et al.   Anti-Cancer Agents in Medicinal Chemistry

Activity of lipoplatin in tumor and in normal cells in vitro

(2010) Chiara Arienti et al.   ANTI-CANCER DRUGS

Not all substrates are treated equally: Implications for mTOR, rapamycin-resistance, and cancer therapy

(2010) Andrew Y. Choo et al.   CELL CYCLE

Bcl-2 Inhibitors: Targeting Mitochondrial Apoptotic Pathways in Cancer Therapy

(2009) M. H. Kang et al.   CLINICAL CANCER RESEARCH

The Discovery of Antiangiogenic Molecules: A Historical Review

(2009) Domenico Ribatti   CURRENT PHARMACEUTICAL DESIGN

Phase III Trial of Cisplatin Plus Gemcitabine With Either Placebo or Bevacizumab As First-Line Therapy for Nonsquamous Non–Small-Cell Lung Cancer: AVAiL

(2009) Martin Reck et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase 1 trial of lipoplatin and gemcitabine as a second-line chemotherapy in patients with nonsmall cell lung carcinoma

(2008) Marios E. Froudarakis et al.   CANCER

Role of copper transporters in resistance to platinating agents

(2008) Cara A. Rabik et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

PCPH/ENTPD5 Expression Confers to Prostate Cancer Cells Resistance against Cisplatin-Induced Apoptosis through Protein Kinase C -Mediated Bcl-2 Stabilization

(2008) J. Villar et al.   CANCER RESEARCH

Significance of Organic Cation Transporter 3 (SLC22A3) Expression for the Cytotoxic Effect of Oxaliplatin in Colorectal Cancer

(2008) S. Yokoo et al.   DRUG METABOLISM AND DISPOSITION

Cancer gene therapy with targeted adenoviruses

(2008) Houria Bachtarzi et al.   Expert Opinion on Drug Delivery

DNA methylation: A promising target for the twenty-first century

(2008) Paula A Abreu et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine

(2008) Carlo Stresemann et al.   INTERNATIONAL JOURNAL OF CANCER

Chemotherapy As an Alternative to Radiotherapy in the Treatment of Stage IIA and IIB Testicular Seminoma: A Spanish Germ Cell Cancer Group Study

(2008) Xavier Garcia-del-Muro et al.   JOURNAL OF CLINICAL ONCOLOGY

A Synthetic Lethal Therapeutic Approach: Poly(ADP) Ribose Polymerase Inhibitors for the Treatment of Cancers Deficient in DNA Double-Strand Break Repair

(2008) Alan Ashworth   JOURNAL OF CLINICAL ONCOLOGY

Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer

(2008) Giorgio Vittorio Scagliotti et al.   JOURNAL OF CLINICAL ONCOLOGY

Role of glutathione S-transferase P1-1 in the cellular detoxification of cisplatin

(2008) Christina Peklak-Scott et al.   MOLECULAR CANCER THERAPEUTICS

Histone Deacetylation

(2008) Anas Al-Janadi et al.   Drugs in research & development